Schistosomiasis elimination: lessons from the past guide the future

Area of Science:

• Tropical medicine
• Infectious diseases
• Public health

Background:

• Schistosomiasis is a major neglected tropical disease affecting over 200 million people globally.
• Current praziquantel-based control programs are unsustainable due to reinfection.
• The disease causes a significant burden, estimated at over 70 million disability-adjusted life-years.

Purpose of the Study:

• To advocate for a shift in funding towards integrated schistosomiasis control strategies.
• To highlight the limitations of current chemotherapy-based programs.
• To emphasize the potential of a multi-faceted approach, including vaccination, for disease elimination.

Main Methods:

• This study presents an argument based on existing knowledge and epidemiological data.
• It analyzes the effectiveness and sustainability of current control methods.
• It proposes a novel integrated control model for schistosomiasis.

Main Results:

• Praziquantel is ineffective against developing schistosomes, hindering long-term control.
• Integrated programs offer a more effective and sustainable solution than chemotherapy alone.
• A transmission-blocking vaccine, even partially effective, is crucial for elimination.

Conclusions:

• A multi-faceted, integrated control program incorporating a vaccine has the potential to eliminate schistosomiasis.
• This approach could significantly improve the health of billions of people in low-income regions.
• Strategic allocation of donor funds towards integrated control is essential for sustainable disease management.